One less-noticed aspect of the Medicare prescription drug program aims to control spending on medicines by paying special attention to high-use patients, something that may give Medicare managed care plans an advantage. The Medicare Modernization Act (MMA) requires prescription drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs) to establish Medication Therapy Management Programs (MTMPs) for seniors with multiple chronic diseases who spend more than $4,000 a year on medicines. The goal is to ensure appropriate prescribing, boost compliance with drug regimens and reduce adverse events for those patients who take several medications.
WASHINGTON, D.C.-One less-noticed aspect of the Medicare prescription drug program aims to control spending on medicines by paying special attention to high-use patients, something that may give Medicare managed care plans an advantage. The Medicare Modernization Act (MMA) requires prescription drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs) to establish Medication Therapy Management Programs (MTMPs) for seniors with multiple chronic diseases who spend more than $4,000 a year on medicines. The goal is to ensure appropriate prescribing, boost compliance with drug regimens and reduce adverse events for those patients who take several medications.
This policy poses challenges for most PDPs, but may provide a competitive advantage for MA-PDs to deliver quality care. Effective MTMP initiatives are likely to boost drug spending as a way to keep patients out of hospitals and doctors' offices. This represents a cost-effective way to provide better care for MA plans that cover both medical services and prescription drugs. But stand-alone PDPs have little to gain from this trade-off.
UPFRONT INVESTMENT
Many PDPs are expected to turn to retail pharmacists or other specialists to provide counseling to patients on appropriate medication use. Plans also may use nurses and other in-house staff to carry out MTMP services. The program may be a boon to all if it succeeds in improving compliance with prescribed medicines and in reducing side effects, and pharmacists support the requirement as a way to gain reimbursement from drug plans.
CMS has provided little guidance on how drug plans should meet the MTMP requirement but promises to do so. The agency will be looking for ways to measure if these programs have an impact on pharmacy compliance and drug safety problems, as well as health outcomes.
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More